267 related articles for article (PubMed ID: 33211908)
1. Botulinum toxin type A therapy for hemifacial spasm.
Duarte GS; Rodrigues FB; Castelão M; Marques RE; Ferreira J; Sampaio C; Moore AP; Costa J
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD004899. PubMed ID: 33211908
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin type A therapy for blepharospasm.
Duarte GS; Rodrigues FB; Marques RE; Castelão M; Ferreira J; Sampaio C; Moore AP; Costa J
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD004900. PubMed ID: 33211907
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin type A therapy for hemifacial spasm.
Costa J; Espírito-Santo C; Borges A; Ferreira JJ; Coelho M; Moore P; Sampaio C
Cochrane Database Syst Rev; 2005 Jan; 2005(1):CD004899. PubMed ID: 15674968
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin type A therapy for cervical dystonia.
Rodrigues FB; Duarte GS; Marques RE; Castelão M; Ferreira J; Sampaio C; Moore AP; Costa J
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD003633. PubMed ID: 33180963
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin type A therapy for cervical dystonia.
Castelão M; Marques RE; Duarte GS; Rodrigues FB; Ferreira J; Sampaio C; Moore AP; Costa J
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD003633. PubMed ID: 29230798
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin type A versus botulinum toxin type B for cervical dystonia.
Duarte GS; Castelão M; Rodrigues FB; Marques RE; Ferreira J; Sampaio C; Moore AP; Costa J
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD004314. PubMed ID: 27782297
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin type B for cervical dystonia.
Marques RE; Duarte GS; Rodrigues FB; Castelão M; Ferreira J; Sampaio C; Moore AP; Costa J
Cochrane Database Syst Rev; 2016 May; 2016(5):CD004315. PubMed ID: 27176573
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin type A versus anticholinergics for cervical dystonia.
Rodrigues FB; Duarte GS; Castelão M; Marques RE; Ferreira J; Sampaio C; Moore AP; Costa J
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD004312. PubMed ID: 33852744
[TBL] [Abstract][Full Text] [Related]
9. Botulinum Toxin for the Treatment of Hemifacial Spasm: An Update on Clinical Studies.
Tambasco N; Filidei M; Nigro P; Parnetti L; Simoni S
Toxins (Basel); 2021 Dec; 13(12):. PubMed ID: 34941718
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin type B for cervical dystonia.
Costa J; Espírito-Santo C; Borges A; Ferreira JJ; Coelho M; Moore P; Sampaio C
Cochrane Database Syst Rev; 2005 Jan; (1):CD004315. PubMed ID: 15674941
[TBL] [Abstract][Full Text] [Related]
11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin type A therapy for blepharospasm.
Costa J; Espírito-Santo C; Borges A; Ferreira JJ; Coelho M; Moore P; Sampaio C
Cochrane Database Syst Rev; 2005 Jan; (1):CD004900. PubMed ID: 15674969
[TBL] [Abstract][Full Text] [Related]
13. [Higher efficacy of botulinum toxin therapy for hemifacial spasm recurrence after vascular decompression. Case report and literature review].
Akulov MA; Shimansky VN; Orlova OR; Zakharov VO; Shevchenko KV; Ogurtsova AA; Orlova AS
Zh Vopr Neirokhir Im N N Burdenko; 2022; 86(2):89-96. PubMed ID: 35412717
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin type A versus botulinum toxin type B for cervical dystonia.
Costa J; Borges A; Espírito-Santo C; Ferreira J; Coelho M; Moore P; Sampaio C
Cochrane Database Syst Rev; 2005 Jan; (1):CD004314. PubMed ID: 15674940
[TBL] [Abstract][Full Text] [Related]
15. Clinical features and response to botulinum toxin in primary and secondary hemifacial spasm.
Pandey S; Jain S
Neurol India; 2018; 66(4):1036-1042. PubMed ID: 30038089
[TBL] [Abstract][Full Text] [Related]
16. Quality of life in hemifacial spasm patient after treatment with botulinum toxin A; a 24-week, double-blind, randomized, cross-over comparison of Dysport and Neuronox study.
Kongsengdao S; Kritalukkul S
J Med Assoc Thai; 2012 Mar; 95 Suppl 3():S48-54. PubMed ID: 22619887
[TBL] [Abstract][Full Text] [Related]
17. An investigation into quality of life improvement in patients undergoing microvascular decompression for hemifacial spasm.
Lawrence JD; Frederickson AM; Chang YF; Weiss PM; Gerszten PC; Sekula RF
J Neurosurg; 2018 Jan; 128(1):193-201. PubMed ID: 28186450
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin for masseter hypertrophy.
Fedorowicz Z; van Zuuren EJ; Schoones J
Cochrane Database Syst Rev; 2013 Sep; 2013(9):CD007510. PubMed ID: 24018587
[TBL] [Abstract][Full Text] [Related]
19. Hemifacial spasm through the last three decades: From etiology to efficacy and safety of long-term botulinum toxin treatment.
Herrero-Infante Y; Rodríguez-Sanz A; Máñez-Miró J; Vivancos-Matellano F
Clin Neurol Neurosurg; 2021 Apr; 203():106555. PubMed ID: 33662742
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin therapy of hemifacial spasm: comparing different therapeutic preparations.
Frei K; Truong DD; Dressler D
Eur J Neurol; 2006 Feb; 13 Suppl 1():30-5. PubMed ID: 16417595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
